We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.4B
AUM Growth
-$406M
Cap. Flow
-$163M
Cap. Flow %
-1.13%
Top 10 Hldgs %
24.27%
Holding
957
New
98
Increased
341
Reduced
353
Closed
82

Top Buys

Rank Stock Value
1
BZ icon
Kanzhun
BZ
+$45.9M
2
STKL
SunOpta
STKL
+$45M
3
ZTO icon
ZTO Express
ZTO
+$44.4M
4
JPM icon
JPMorgan Chase
JPM
+$39.9M
5
XIFR
XPLR Infrastructure LP
XIFR
+$36.1M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$79.9M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
VERU icon
Veru
VERU
+$53.9M
4
PG icon
Procter & Gamble
PG
+$50.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 26.5%
3 Financials 9.1%
4 Consumer Discretionary 8.02%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LII icon
726
Lennox International
LII
$15B
$545K ﹤0.01%
2,357
-354
-13% -$89.3K
MTN icon
727
Vail Resorts
MTN
$5.7B
$540K ﹤0.01%
2,512
-444
-15% -$107K
LSXMA
728
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
$536K ﹤0.01%
28,214
+9,287
+49% +$233K
CRL icon
729
Charles River Laboratories
CRL
$11.3B
$532K ﹤0.01%
2,866
-2,287
-44% -$518K
SU icon
730
Suncor Energy
SU
$77.7B
$528K ﹤0.01%
18,487
-1,515
-8% -$49.3K
AMH icon
731
American Homes 4 Rent
AMH
$12.1B
$518K ﹤0.01%
17,886
-3,221
-15% -$103K
OPCH icon
732
Option Care Health
OPCH
$3.58B
$515K ﹤0.01%
17,620
-30,860
-64% -$925K
APA icon
733
APA Corp
APA
$13B
$504K ﹤0.01%
15,184
NVRO
734
DELISTED
NEVRO CORP.
NVRO
$499K ﹤0.01%
14,996
-6,282
-30% -$221K
DISH
735
DELISTED
DISH Network Corp.
DISH
$496K ﹤0.01%
57,700
+15,165
+36% +$191K
STGW icon
736
Stagwell
STGW
$2B
$487K ﹤0.01%
+71,317
New +$499K
CNMD icon
737
CONMED
CNMD
$1.3B
$483K ﹤0.01%
+5,048
New +$488K
CARS icon
738
Cars.com
CARS
$722M
$482K ﹤0.01%
27,115
+1,078
+4% +$18.3K
SGRY icon
739
Surgery Partners
SGRY
$2.15B
$481K ﹤0.01%
+15,145
New +$492K
MASI
740
DELISTED
Masimo
MASI
$478K ﹤0.01%
2,813
-553
-16% -$93.3K
CSTL icon
741
Castle Biosciences
CSTL
$742M
$477K ﹤0.01%
22,812
-14,783
-39% -$361K
CNK icon
742
Cinemark Holdings
CNK
$4.07B
$476K ﹤0.01%
+34,938
New +$424K
DT icon
743
Dynatrace
DT
$12.7B
$473K ﹤0.01%
12,161
-1,404
-10% -$56.8K
OMCL icon
744
Omnicell
OMCL
$1.88B
$472K ﹤0.01%
+8,743
New +$482K
FNF icon
745
Fidelity National Financial
FNF
$14.4B
$468K ﹤0.01%
+14,563
New +$573K
CABO icon
746
Cable One
CABO
$237M
$467K ﹤0.01%
722
+193
+36% +$140K
HAE icon
747
Haemonetics
HAE
$3.88B
$466K ﹤0.01%
+6,123
New +$496K
MMSI icon
748
Merit Medical Systems
MMSI
$4.82B
$463K ﹤0.01%
6,798
-5,746
-46% -$403K
FFIV icon
749
F5
FFIV
$22B
$456K ﹤0.01%
3,401
-616
-15% -$88.9K
TW icon
750
Tradeweb Markets
TW
$23B
$455K ﹤0.01%
6,257
-992
-14% -$71.8K

Similar funds

Candriam SCA's Q1 2023 Portfolio in Review

As of Q1 2023, Candriam SCA held 957 positions worth $14.4B, down 2.7% from $14.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2023 filing shows 98 new, 341 increased, 353 reduced and 82 closed positions. Its largest new stake was Kanzhun: 2,106,130 shares worth $36.9M. The largest sale was Mercado Libre, an estimated $79.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2023 buy was Kanzhun: 2,106,130 shares worth $36.9M.
  • Candriam SCA added most to SunOpta in Q1 2023, an estimated $45M increase.
  • Candriam SCA's biggest Q1 2023 reduction was Mercado Libre, cutting an estimated $79.9M.
  • Candriam SCA fully exited Veru in Q1 2023, selling an estimated $53.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.4B portfolio in Q1 2023.
  • Candriam SCA opened 98 new positions and closed 82 in Q1 2023.
  • Candriam SCA's portfolio value fell 2.7% quarter-over-quarter to $14.4B.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.